Exenatide twice daily versus glimepiride for prevention of glycaemic deterioration in patients with type 2 diabetes with metformin failure (EUREXA): an open-label, randomised controlled trial

Gallwitz, Baptist; Guzman, Juan; Dotta, Francesco; Guerci, Bruno; Simo, Rafael; Basson, Bruce R.; Festa, Andreas; Kiljanski, Jacek; Sapin, Helene; Trautmann, Michael; Schernthaner, Guntram

dc.contributor.author	Gallwitz, Baptist	de_DE
dc.date.accessioned	2014-04-02T13:23:52Z
dc.date.available	2014-04-02T13:23:52Z
dc.date.issued	2012	de_DE
dc.identifier.issn	0140-6736	de_DE
dc.identifier.uri	http://hdl.handle.net/10900/50836
dc.language.iso	en	en
dc.publisher	Elsevier Science Inc	de_DE
dc.relation.uri	http://dx.doi.org/10.1016/S0140-6736(12)60479-6	de_DE
dc.rights	info:eu-repo/semantics/closedAccess
dc.subject.ddc	610	de_DE
dc.title	Exenatide twice daily versus glimepiride for prevention of glycaemic deterioration in patients with type 2 diabetes with metformin failure (EUREXA): an open-label, randomised controlled trial	de_DE
dc.type	Article	de_DE
utue.quellen.id	20140226071329_01997	de_DE
utue.publikation.seiten	2270-2278	de_DE
utue.personen.roh	Gallwitz, Baptist	de_DE
utue.personen.roh	Guzman, Juan	de_DE
utue.personen.roh	Dotta, Francesco	de_DE
utue.personen.roh	Guerci, Bruno	de_DE
utue.personen.roh	Simo, Rafael	de_DE
utue.personen.roh	Basson, Bruce R.	de_DE
utue.personen.roh	Festa, Andreas	de_DE
utue.personen.roh	Kiljanski, Jacek	de_DE
utue.personen.roh	Sapin, Helene	de_DE
utue.personen.roh	Trautmann, Michael	de_DE
utue.personen.roh	Schernthaner, Guntram	de_DE
dcterms.isPartOf.ZSTitelID	Lancet	de_DE
dcterms.isPartOf.ZS-Issue	9833	de_DE
dcterms.isPartOf.ZS-Volume	379	de_DE
utue.fakultaet	04 Medizinische Fakultät	de_DE